Patents Assigned to KeyView Labs, Inc.
  • Patent number: 10201577
    Abstract: A nutritional supplement composition and associated method enhances working and long term memory support in a healthy adult person, and includes a Panax Ginseng extract and Ginkgo Biloba extract in a ratio a:b, wherein a for the Panax Ginseng extract is between about 1.9 and 2.8 and b for the Ginkgo Biloba extract is between bout 0.8 and 1.1. It is formulated for oral administration such that the Panax Ginseng extract and Ginkgo Biloba extract together account for at least 90 wt % of a dosage unit of the nutritional supplement composition. The Panax Ginseng extract and Ginkgo Biloba extract together may be present in the amount from about 320 mg to 960 mg. The dosage unit of the composition may be equal to or less than about 1,000 mg.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: February 12, 2019
    Assignee: KEYVIEW LABS, INC.
    Inventor: Scott Eibel
  • Patent number: 10105406
    Abstract: A nutritional supplement composition for enhancing cognitive function includes Ginkgo biloba, rhodiola, acetyl-L-carnitine and huperzine A. The Ginkgo biloba, rhodiola and acetyl-L-carnitine are in a ratio a:b:c respectively such that a as the Ginkgo biloba is between about 690 and 1030, b as the rhodiola is between about 1,700 and 2,600 and c as the acetyl-L-carnitine is between about 8,000 and 12,000. The composition is formulated for oral administration and the Ginkgo biloba, rhodiola, acetyl-L-carnitine and huperzine A together account for at least 80 wt % of a dosage unit of the nutritional supplement composition.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: October 23, 2018
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 10105405
    Abstract: A nutritional supplement composition is formulated for oral administration and enhances cognitive function. It includes huperzine A, Ginkgo biloba, and acetyl-L-carnitine. The huperzine A, acetyl-L-carnitine, and Ginkgo biloba together account for at least 80 wt % of a dosage unit of the composition. The Ginkgo biloba is about 5.0% to about 12.0%, by weight of the huperzine A, acetyl-L-carnitine and Ginkgo biloba. The Ginkgo biloba and acetyl-L-carnitine are in a ratio of y:z respectively, wherein y is between about 690 and 1,030 for Ginkgo biloba and z is between about 8,000 and 12,000 for acetyl-L-carnitine.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: October 23, 2018
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 9737519
    Abstract: Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieved the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: August 22, 2017
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 9737580
    Abstract: A nutritional supplement composition enhances cognitive function and includes huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola. The composition is formulated for oral administration. The huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola are in a ratio a:b:c:d: respectively such that a as the huperzine A is between about 0.8 and 1.2, b as vinpocetine is between about 80 and 120, c as rhodiola is about 1,600 and 2,400, and d as the acetyl-L-carnitine is between about 8,000 and 12,000.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: August 22, 2017
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 9603884
    Abstract: A nutritional supplement composition enhances cognitive function and includes huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola. The composition is formulated for oral administration. The huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola are in a ratio a:b:c:d: respectively such that a as the huperzine A is between about 0.8 and 1.2, b as vinpocetine is between about 80 and 120, c as rhodiola is about 1,600 and 2,400, and d as the acetyl-L-carnitine is between about 8,000 and 12,000.
    Type: Grant
    Filed: January 18, 2016
    Date of Patent: March 28, 2017
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 9498469
    Abstract: Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieved the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: November 22, 2016
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 9327002
    Abstract: Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieved the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: May 3, 2016
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 9308232
    Abstract: A nutritional supplement composition enhances cognitive function and includes huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola. The composition is formulated for oral administration. The huperzine A, vinpocetine, acetyl-L-carnitine, and rhodiola are in a ratio a:b:c:d: respectively such that a as the huperzine A is between about 0.8 and 1.2, b as vinpocetine is between about 80 and 120, c as rhodiola is about 1,600 and 2,400, and d as the acetyl-L-carnitine is between about 8,000 and 12,000.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: April 12, 2016
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds
  • Patent number: 8883814
    Abstract: Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieve the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: November 11, 2014
    Assignee: KeyView Labs, Inc.
    Inventor: Josh Reynolds